Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.5400
-0.0200 (-3.57%)
Feb 27, 2026, 2:22 PM EST
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 27.99 million as of March 2, 2026. Its market cap has increased by 1.38% in one year.
Market Cap
27.99M
Enterprise Value
24.49M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.54
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 27.99M, an increase of 100.58%. That is a compound annual growth rate of 19.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 27.99M | -16.92% |
| Dec 31, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 47.47M |
| Devonian Health Group | 38.03M |
| BriaCell Therapeutics | 37.78M |
| Defence Therapeutics | 35.00M |
| Resverlogix | 34.73M |
| Microbix Biosystems | 33.25M |
| Telescope Innovations | 28.69M |
| Rapid Dose Therapeutics | 20.28M |